Wilson Classes
A brief history of "The Convergence" What we now call "The Convergence" began in 2015, with Pilgrim Pharmaceuticals announcement of a vaccine to prevent against most forms of cancer. They had been quietly testing it on 1,000 people for over 2 years and had been running a 10,000 person clinical trial for another year. Not one of these people, which included a significant number of "high risk" patients was diagnosed with any form of cancer. The US FDA, and counterparts across the globe,...